Navigation Links
MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
Date:3/4/2008

Note payable - 75,000

Deferred product revenue - 189,000

Total current liabilities 7,273,296 17,255,849

Warrant liability 2,100,000 -

Deferred contract revenue 11,625,000 11,625,000

Deferred rent and credit on lease

concession 1,177,840 1,252,900

Total liabilities 22,176,136 30,133,749

Noncontrolling interest 7,337,811 -

Commitments and contingencies

Stockholders' equity (deficit):

Preferred stock, undesignated - -

Common stock, par value 467,488 363,625

Capital in excess of par value 189,019,188 164,593,930

Accumulated deficit (195,334,828) (153,085,462)

Accumulated other comprehensive loss - (73)

Total stockholders' equity (deficit) (5,848,152) 11,872,020

Total liabilities and

stockholders' equity (deficit) $23,665,795 $42,005,769

MIDDLEBROOK PHARMACEUTICALS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

Year Ended December 31,

2007 2006

Cash flows from operating activities:

Net loss $(42,249,366) $(41,990,154)

Adjustments to reconcile net income

to net cash used in operating

activities:

Loss attributable to non-

controlling interest (162,189)
'/>"/>

SOURCE MiddleBrook Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. MiddleBrook Pharmaceuticals Closes Private Placement of Common Equity Raising $21 Million
2. MiddleBrook Pharmaceuticals to Present at BIO CEO & Investor Conference 2008
3. MiddleBrook Pharmaceuticals to Announce Fourth Quarter and Full Year 2007 Financial Results on March 4, 2008
4. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
5. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
8. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
9. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
10. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
11. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Bethesda, MD (PRWEB) December 23, 2014 ... signed into law H.R. 83, the Omnibus and ... the first time, made hydrocephalus a condition eligible ... Research Programs (CDMRP) administered by the Department of ... conjunction with its allies on Capitol Hill, is ...
(Date:12/24/2014)... 2014 The report expects global cell ... 2019. It also provides a carefully analyzed data about ... for the market. , Full Copy of Report @ ... global market for cell expansion will keep witnessing growth ... this growth to be driven by rapid technological advancements, ...
(Date:12/24/2014)... 23, 2014 PharmaBoardroom,s new ... today and available for free download , digs deep ... and growth in the sector today. One area ... has been in developing a homegrown pharmaceutical manufacturing base, even ... still remains some way off. A cursory comparison with neighboring ...
(Date:12/22/2014)... December 22, 2014 The Center ... leader of technical training across the life sciences industry, ... Management (SCDM) to provide the organization's members with ... —providing access to the more than 350 sessions across ... with 10% off when registering for a public ...
Breaking Biology Technology:Rare Brain Condition Now Eligible for Department of Defense Research Dollars 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 3PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3CfPIE Announces Partnership with the Society for Clinical Data Management 2CfPIE Announces Partnership with the Society for Clinical Data Management 3
... ,Winston Laboratories, Inc., a company engaged in the ... Getting Ready Corporation,a publicly-traded company with no active ... 2008, pursuant to a merger agreement providing,for the ... Corp., a,wholly-owned subsidiary of GTRY. Winston will continue ...
... Sept. 26 Dr. Qi Lu, former EVP of,Yahoo!, continues ... as the president of HYSTA, USA. HYSTA is greatly,honored to ... Yahoo! at end of August, he had served more than ... and professionally,but one thing that has not changed is his ...
... researchers at the University of Iowa and the University of ... (CF) that appears to closely mimic the disease in human ... piglets and human newborns with CF suggest that this new ... also speed discovery of new treatments. The study is published ...
Cached Biology Technology:Getting Ready Corporation and Winston Laboratories, Inc. Announce Completion of Merger 2Getting Ready Corporation and Winston Laboratories, Inc. Announce Completion of Merger 3Getting Ready Corporation and Winston Laboratories, Inc. Announce Completion of Merger 4HYSTA Announces Dr. Qi Lu to continue on as President of HYSTA, USA 2Researchers develop new model for cystic fibrosis 2
(Date:12/17/2014)... Dec. 16, 2014 Research and Markets ... of the "Global Chemical Sensor Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 One major ... demand for medical sensors in biomedical applications. Chemical ... quick and correct diagnosis during surgical procedures. The ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has ... in the APAC Region 2015-2019"  report to their ... in this market is advances in technology. With ... upgrade biometric solutions to the latest standard that ...
(Date:12/11/2014)... Minn. , Dec. 10, 2014  Data ... physiologic monitoring, has released a new series of ... of preclinical toxicology researchers. M series, part of ... toxicologists collect the best possible physiologic data when ... Adding functional endpoints to toxicology studies has ...
Breaking Biology News(10 mins):Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2New telemetry implants expected to change how large animal toxicology studies are conducted 2
... University in St. Louis have made an important breakthrough in ... extra genes using short bits of RNA. Basically, they have ... in the pathway unfold within the cell, and seeing is ... , Craig Pikaard, Ph.D., Washington University professor ...
... A gene that enables rice to survive complete ... at the International RiceResearch Institute in the Philippines ... campuses. The discovery allows fordevelopment of new rice ... agriculture's oldest challenges and offering reliefto millions of ...
... damaged DNA can lead to human diseases such as cancer, ... , Now, computational chemists at the University of Georgia ... is knocked off one of the pairs of bases that ... "lesions" in the DNA. These lesions, when replicated in the ...
Cached Biology News:Pathway toward gene silencing described in plants 2Pathway toward gene silencing described in plants 3Pathway toward gene silencing described in plants 4New flood-tolerant rice offers relief for world's poorest farmers 2New flood-tolerant rice offers relief for world's poorest farmers 3'Pinball protons' created by ultraviolet rays and other causes can lead to DNA damage 2
... Overhead Drive for individual and parallel agitation ... agitation of DASGIP vessels, featuring range of ... ,Up to 16 overhead drives can be ... Systems fedbatch-pro® and cellferm-pro® for microbiology and ...
This kit is designed to select cells labeled with biotinylated antibodies. Kit includes reagents for labeling 3 x 10 9 cells and EasySep magnet....
Designed for use with the Agencourt CleanSEQ and Agencourt AMPure 384-well SPRI reagent kits. For use with 384-well thermal cycling plates....
SDS-OutT Precipitation Reagent...
Biology Products: